GAS6 expression identifies high-risk adult AML patients: potential implications for therapy
      QxMD      Google Scholar   
Citation:
Leukemia vol 28 (6) 1252-1258
Year:
2014
Type:
Manuscript
Funding:
NCTN
Endpoint:
Secondary
Analysis:
Primary
Data Sharing:
No-Data-Sharing
Status:
Presented/Published
Citation Status:
ppub
Note:
Methodological:
No
Biospecimen:
Yes
SDC:
No
Book Volume:
3
Parents:
780  
Children:
None
Program:
TRP
Primary Committee:
Leuk Corr Sci
Sec. Committees:
   
Pharmas:
 
Grants:
CA33601, P50 CA140158, U10 CA180861, CA140158, CA16058, CA101140, U10 CA077658, U10 CA031946, R21 CA129657, U10 CA033601, U24 CA114725, U10 CA101140, U10 CA180882, P30 CA016058, CA77658, CA129657, CA114725, T32 CA009338, CA31946  
Corr. Author:
 
Authors:
                                           
Networks:
 
Study
Multiple Studies, or Legacy Studies in Alliance Study:
CALGB-8525, CALGB-8923, CALGB-9420, CALGB-9621, CALGB-9720, CALGB-10201, CALGB-19808
Phases:
1, 3
Keywords:
GAS6, acute myeloid leukemia, prognosis